GRIGNANI, Giulia
GRIGNANI, Giulia
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
2021-01-01 Strauss S.J.; Frezza A.M.; Abecassis N.; Bajpai J.; Bauer S.; Biagini R.; Bielack S.; Blay J.Y.; Bolle S.; Bonvalot S.; Boukovinas I.; Bovee J.V.M.G.; Boye K.; Brennan B.; Brodowicz T.; Buonadonna A.; de Alava E.; Dei Tos A.P.; Garcia del Muro X.; Dufresne A.; Eriksson M.; Fagioli F.; Fedenko A.; Ferraresi V.; Ferrari A.; Gaspar N.; Gasperoni S.; Gelderblom H.; Gouin F.; Grignani G.; Gronchi A.; Haas R.; Hassan A.B.; Hecker-Nolting S.; Hindi N.; Hohenberger P.; Joensuu H.; Jones R.L.; Jungels C.; Jutte P.; Kager L.; Kasper B.; Kawai A.; Kopeckova K.; Krakorova D.A.; Le Cesne A.; Le Grange F.; Legius E.; Leithner A.; Lopez Pousa A.; Martin-Broto J.; Merimsky O.; Messiou C.; Miah A.B.; Mir O.; Montemurro M.; Morland B.; Morosi C.; Palmerini E.; Pantaleo M.A.; Piana R.; Piperno-Neumann S.; Reichardt P.; Rutkowski P.; Safwat A.A.; Sangalli C.; Sbaraglia M.; Scheipl S.; Schoffski P.; Sleijfer S.; Strauss D.; Sundby Hall K.; Trama A.; Unk M.; van de Sande M.A.J.; van der Graaf W.T.A.; van Houdt W.J.; Frebourg T.; Ladenstein R.; Casali P.G.; Stacchiotti S.
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma
2021-01-01 Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y.
Front-line window therapy with temozolomide and irinotecan in patients with primary disseminated multifocal ewing sarcoma: Results of the isg/aieop ew-2 study
2021-01-01 Asaftei S.D.; Puma N.; Paioli A.; Petraz M.; Morosi C.; Podda M.; Tamburini A.; Palmerini E.; Coccoli L.; Grignani G.; Manzitti C.; Bertulli R.; De Leonardis F.; Rabusin M.; Campello A.; Tirtei E.; Picci P.; Prete A.; Longhi A.; Fagioli F.; Luksch R.
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
2018-01-01 Palmerini, E.*; Jones, R.L.; Setola, E.; Picci, P.; Marchesi, E.; Luksch, R.; Grignani, G.; Cesari, M.; Longhi, A.; Abate, M.E.; Paioli, A.; Szucs, Z.; D’ambrosio, L.; Scotlandi, K.; Fagioli, F.; Asaftei, S.; Ferrari, S.
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study
2021-01-01 Pignochino Y.; Crisafulli G.; Giordano G.; Merlini A.; Berrino E.; Centomo M.L.; Chiabotto G.; Brusco S.; Basirico M.; Maldi E.; Pisacane A.; Leuci V.; Sangiolo D.; D'ambrosio L.; Aglietta M.; Kasper B.; Bardelli A.; Grignani G.
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients (Cancer (2009) 115, (2980-2987))
2009-01-01 Berger M.; Grignani G.; Ferrari S.; Biasin E.; Brach Del Prever A.; Aliberti S.; Saglio F.; Aglietta M.; Fagioli F.
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
2021-01-01 Gronchi, A; Miah, A B; Dei Tos, A P; Abecassis, N; Bajpai, J; Bauer, S; Biagini, R; Bielack, S; Blay, J Y; Bolle, S; Bonvalot, S; Boukovinas, I; Bovee, J V M G; Boye, K; Brennan, B; Brodowicz, T; Buonadonna, A; De Álava, E; Del Muro, X G; Dufresne, A; Eriksson, M; Fagioli, F; Fedenko, A; Ferraresi, V; Ferrari, A; Frezza, A M; Gasperoni, S; Gelderblom, H; Gouin, F; Grignani, G; Haas, R; Hassan, A B; Hecker-Nolting, S; Hindi, N; Hohenberger, P; Joensuu, H; Jones, R L; Jungels, C; Jutte, P; Kager, L; Kasper, B; Kawai, A; Kopeckova, K; Krákorová, D A; Le Cesne, A; Le Grange, F; Legius, E; Leithner, A; Lopez-Pousa, A; Martin-Broto, J; Merimsky, O; Messiou, C; Mir, O; Montemurro, M; Morland, B; Morosi, C; Palmerini, E; Pantaleo, M A; Piana, R; Piperno-Neumann, S; Reichardt, P; Rutkowski, P; Safwat, A A; Sangalli, C; Sbaraglia, M; Scheipl, S; Schöffski, P; Sleijfer, S; Strauss, D; Strauss, S; Sundby Hall, K; Trama, A; Unk, M; van de Sande, M A J; van der Graaf, W T A; van Houdt, W J; Frebourg, T; Casali, P G; Stacchiotti, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
| Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ | 2021 | Strauss S.J.; Frezza A.M.; Abecassis N.; Bajpai J.; Bauer S.; Biagini R.; Bielack S.; Blay J.Y.; Bolle S.; Bonvalot S.; Boukovinas I.; Bovee J.V.M.G.; Boye K.; Brennan B.; Brodowicz T.; Buonadonna A.; de Alava E.; Dei Tos A.P.; Garcia del Muro X.; Dufresne A.; Eriksson M.; Fagioli F.; Fedenko A.; Ferraresi V.; Ferrari A.; Gaspar N.; Gasperoni S.; Gelderblom H.; Gouin F.; Grignani G.; Gronchi A.; Haas R.; Hassan A.B.; Hecker-Nolting S.; Hindi N.; Hohenberger P.; Joensuu H.; Jones R.L.; Jungels C.; Jutte P.; Kager L.; Kasper B.; Kawai A.; Kopeckova K.; Krakorova D.A.; Le Cesne A.; Le Grange F.; Legius E.; Leithner A.; Lopez Pousa A.; Martin-Broto J.; Merimsky O.; Messiou C.; Miah A.B.; Mir O.; Montemurro M.; Morland B.; Morosi C.; Palmerini E.; Pantaleo M.A.; Piana R.; Piperno-Neumann S.; Reichardt P.; Rutkowski P.; Safwat A.A.; Sangalli C.; Sbaraglia M.; Scheipl S.; Schoffski P.; Sleijfer S.; Strauss D.; Sundby Hall K.; Trama A.; Unk M.; van de Sande M.A.J.; van der Graaf W.T.A.; van Houdt W.J.; Frebourg T.; Ladenstein R.; Casali P.G.; Stacchiotti S. | |
| Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma | 2021 | Giordano G.; Merlini A.; Ferrero G.; Mesiano G.; Fiorino E.; Brusco S.; Centomo M.L.; Leuci V.; D'ambrosio L.; Aglietta M.; Sangiolo D.; Grignani G.; Pignochino Y. | |
| Front-line window therapy with temozolomide and irinotecan in patients with primary disseminated multifocal ewing sarcoma: Results of the isg/aieop ew-2 study | 2021 | Asaftei S.D.; Puma N.; Paioli A.; Petraz M.; Morosi C.; Podda M.; Tamburini A.; Palmerini E.; Coccoli L.; Grignani G.; Manzitti C.; Bertulli R.; De Leonardis F.; Rabusin M.; Campello A.; Tirtei E.; Picci P.; Prete A.; Longhi A.; Fagioli F.; Luksch R. | |
| Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients | 2018 | Palmerini, E.*; Jones, R.L.; Setola, E.; Picci, P.; Marchesi, E.; Luksch, R.; Grignani, G.; Cesari, M.; Longhi, A.; Abate, M.E.; Paioli, A.; Szucs, Z.; D’ambrosio, L.; Scotlandi, K.; Fagioli, F.; Asaftei, S.; Ferrari, S. | |
| Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study | 2021 | Pignochino Y.; Crisafulli G.; Giordano G.; Merlini A.; Berrino E.; Centomo M.L.; Chiabotto G.; Brusco S.; Basirico M.; Maldi E.; Pisacane A.; Leuci V.; Sangiolo D.; D'ambrosio L.; Aglietta M.; Kasper B.; Bardelli A.; Grignani G. | |
| Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients (Cancer (2009) 115, (2980-2987)) | 2009 | Berger M.; Grignani G.; Ferrari S.; Biasin E.; Brach Del Prever A.; Aliberti S.; Saglio F.; Aglietta M.; Fagioli F. | |
| Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up | 2021 | Gronchi, A; Miah, A B; Dei Tos, A P; Abecassis, N; Bajpai, J; Bauer, S; Biagini, R; Bielack, S; Blay, J Y; Bolle, S; Bonvalot, S; Boukovinas, I; Bovee, J V M G; Boye, K; Brennan, B; Brodowicz, T; Buonadonna, A; De Álava, E; Del Muro, X G; Dufresne, A; Eriksson, M; Fagioli, F; Fedenko, A; Ferraresi, V; Ferrari, A; Frezza, A M; Gasperoni, S; Gelderblom, H; Gouin, F; Grignani, G; Haas, R; Hassan, A B; Hecker-Nolting, S; Hindi, N; Hohenberger, P; Joensuu, H; Jones, R L; Jungels, C; Jutte, P; Kager, L; Kasper, B; Kawai, A; Kopeckova, K; Krákorová, D A; Le Cesne, A; Le Grange, F; Legius, E; Leithner, A; Lopez-Pousa, A; Martin-Broto, J; Merimsky, O; Messiou, C; Mir, O; Montemurro, M; Morland, B; Morosi, C; Palmerini, E; Pantaleo, M A; Piana, R; Piperno-Neumann, S; Reichardt, P; Rutkowski, P; Safwat, A A; Sangalli, C; Sbaraglia, M; Scheipl, S; Schöffski, P; Sleijfer, S; Strauss, D; Strauss, S; Sundby Hall, K; Trama, A; Unk, M; van de Sande, M A J; van der Graaf, W T A; van Houdt, W J; Frebourg, T; Casali, P G; Stacchiotti, S |